Federal contract award
75FCMC22F0040
MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | OFC OF ACQUISITION AND GRANTS MGMT |
| NAICS | 541910 — Marketing Research and Public Opinion Polling |
| PSC | R422 — Market Research and Public Opinion Services (includes telephone and field interviews, focus testing, and surveys) |
| Parent award / vehicle | 47QRAA20D0072 |
| Set-aside | WOMEN OWNED SMALL BUSINESS SOLE SOURCE |
| Pricing type | TIME AND MATERIALS |
| Obligations | $9.4M |
| Current contract value | $9.4M |
| Potential contract value / ceiling | $12.6M |
| Start date | Jun 1, 2022 |
| Current end date | May 31, 2027 |
| Potential end date | May 31, 2027 |
| Latest award activity | May 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 16 of 16 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 1, 2026 | P00015 | $1.2M | EO 14398, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS |
| Feb 18, 2026 | P00014 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Apr 30, 2025 | P00013 | $1.5M | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Apr 8, 2025 | P00012 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Jan 8, 2025 | P00011 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Dec 19, 2024 | P00010 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Nov 26, 2024 | P00009 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Apr 29, 2024 | P00008 | $1.4M | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Nov 7, 2023 | P00007 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| May 30, 2023 | P00006 | $1.8M | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Apr 10, 2023 | P00005 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Nov 22, 2022 | P00004 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Aug 9, 2022 | P00003 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Jun 7, 2022 | P00002 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Jun 2, 2022 | P00001 | $0 | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
| Jun 1, 2022 | 0 | $3.5M | MEDICARE FEE-FOR-SERVICE (FFS) - PHYSICIAN FEE SCHEDULE (PFS)/OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) AND MEDICARE ADVANTAGE (PART C)/ PRESCRIPTION DRUG (PART D) PUBLIC COMMENT SUPPORT |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-05-31 (218 days from calculation)
- +35 points
- 24 historical awards in this buyer and category group
- +15 points
- 16 recorded award transactions
- +10 points
- Latest award action: 2026-05-01
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.